A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.
What the source actually supports
- Evidence stage
- Phase not reported
- Study design
- NA · SINGLE GROUP · TREATMENT · NONE
- Evidence population
- Human clinical study registration
- Participants
- 45
- Population
- ALL · 65 Years to 79 Years
- Duration
- 2025-03-01 to 2025-06-01
- Intervention
- Combined aerobic and resistance exercise
- Comparator
- Not reported
- Outcomes measured
- Change From Baseline in Glycated Hemoglobin at 12 Weeks — Baseline and 12 weeks; Change From Baseline in Fasting Plasma Glucose at 12 Weeks — Baseline and 12 weeks; Change From Baseline in Montreal Cognitive Assessment Total Score at 12 Weeks — Baseline and 12 weeks; Change From Baseline in Fasting Insulin at 12 Weeks — Baseline and 12 weeks; Change From Baseline in Total Cholesterol at 12 Weeks — Baseline and 12 weeks; Change From Baseline in Triglycerides at 12 Weeks — Baseline and 12 weeks; Change From Baseline in High-Density Lipoprotein Cholesterol at 12 Weeks — Baseline and 12 weeks; Change From Baseline in Low-Density Lipoprotein Cholesterol at 12 Weeks — Baseline and 12 weeks; Change From Baseline in Body Weight at 12 Weeks — Baseline and 12 weeks; Change From Baseline in Muscle Mass at 12 Weeks — Baseline and 12 weeks; Change From Baseline in Body Mass Index at 12 Weeks — Baseline and 12 weeks; Change From Baseline in Body Fat Percentage at 12 Weeks — Baseline and 12 weeks; Change From Baseline in Vital Capacity Measured Using a GMCS-FHL3 Vital Capacity Tester at 12 Weeks — Baseline and 12 w…; Change From Baseline in Relative Handgrip Strength, Calculated as Maximum Handgrip Strength Divided by Body Weight, at…; Change From Baseline in Sit-and-Reach Performance at 12 Weeks — Baseline and 12 weeks; Change From Baseline in 30-Second Sit-to-Stand Performance at 12 Weeks — Baseline and 12 weeks; Change From Baseline in One-Legged Standing With Eyes Closed at 12 Weeks — Baseline and 12 weeks; Change From Baseline in Choice Reaction Time at 12 Weeks — Baseline and 12 weeks
- Reported result
- No reusable finding-level result is available in this record.
Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.
Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.
Source supportStructured registry protocol metadata; no finding-level conclusion is generated.
Registration and recruitment status do not establish safety, efficacy, or regulatory approval.
Why this record appears here · 100% topic match
The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.
- Exercise · 100%Title contains controlled topic terminology. Summary contains controlled topic terminology. Source terminology contains a controlled topic term. Title supplies ageing or longevity context.
Automated source check 100% · update recency 100%. These figures help sort records; they are not medical ratings.